Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.84 |
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16177 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL33449 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL2418469 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL24551 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL16774769 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL261591 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL111093 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL262456 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL7353068 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL12977796 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1841 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074553-A | Process for cutting goat milk into small molecules by aseptic high-pressure high-speed rotation | — | 2026-05-26 | — | — | CN | claimed |
| EP-4192923-B1 | HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF | HERCULES LLC (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2025125201-A1 | AQUEOUS DISPERSION COMPRISING POLYMER PARTICLES FOR IMPROVING THE RESISTANCE OF WATERBORNE COATINGS | BASF SE (DE) | 2025-06-19 | — | — | WO | claimed |
| CN-120038997-A | Composite functional waterproof breathable film and preparation method and application thereof | 廊坊美德宝科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-116376488-B | Water-based epoxy resin adhesive | 万华化学集团股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119916642-A | Photosensitive dry film and preparation method and application thereof | 东莞市彼艾斯电子科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119684880-A | Fingerprint-resistant paint for color plates and color plate production process | 合肥禾盛新型材料有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-116324124-B | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-116324123-B | Hydrophobically modified associative thickener polymer and preparation method and application thereof | 赫尔克里士有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119638591-A | Preparation method and application of cetyl-PG hydroxyethyl palmitamide | 南京先达医药科技有限公司 | 2025-03-18 | — | — | CN | claimed |
| US-20050220889-A1 | Ion binding compositions | SYMYX THERAPEUTICS, INC. (US) | 2005-10-06 | — | — | US | claimed |
| US-20050220890-A1 | Ion binding compositions | SYMYX THERAPEUTICS, INC. (US) | 2005-10-06 | — | — | US | claimed |
| US-20030211951-A1 | Lubricant composition containing phosphorous, molybdenum, and hydroxy-substituted dithiocarbamates | AFTON CHEMICAL INTANGIBLES LLC | 2003-11-13 | — | — | US | claimed |
| US-6627751-B1 | Alkylating alkali cellulose with haloacetic or vinylsulfonic acids and salts, ethers and/or ammonium compounds to form carboxyalkyl cellulose and salts used as protective colloids, stabilizer, emulsifiers or thickeners | AKKO NOBEL N.V. (NL) | 2003-09-30 | — | — | US | claimed |
| CN-1443834-A | Lubricating oil composite containing phosphorus, molybdenum and hydroxyl substituted dithiocarbamate | ETHYL CO (US) | 2003-09-24 | — | — | CN | claimed |
| EP-0991668-B1 | HYDROPHOBICALLY MODIFIED ANIONIC CELLULOSE ETHERS | AKZO NOBEL NV (NL) | 2003-01-02 | — | — | EP | claimed |
| WO-2001038398-A1 | HYDROPHOBICALLY MODIFIED POLYOLS | AKZO NOBEL N.V. (NL) | 2001-05-31 | — | — | WO | claimed |
| EP-0991668-A1 | HYDROPHOBICALLY MODIFIED ANIONIC CELLULOSE ETHERS | Akzo Nobel N.V. (NL) | 2000-04-12 | — | — | EP | claimed |
| WO-1998056825-A1 | HYDROPHOBICALLY MODIFIED ANIONIC CELLULOSE ETHERS | AKZO NOBEL N.V. (NL) | 1998-12-17 | — | — | WO | claimed |
| EP-0471866-A1 | Modified water-soluble cellulose ether | Shin-Etsu Chemical Co., Ltd. (JP) | 1992-02-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050220890-A1 | Ion binding compositions | SLC10A1, SLC8B1, ATP2A3 | ALDH1A1 3384/4885TDP1 4758/4885SMN1; SMN2 4510/4885 |
| US-20050220889-A1 | Ion binding compositions | SLC10A1, SLC8B1, ATP2A3 | ALDH1A1 3384/4885TDP1 4758/4885SMN1; SMN2 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.